LgR5 has been demonstrated to be involved in the pathogenesis of different human cancer entities, including hepatocellular carcinoma [28], basal cell carcinoma [29], endometrial cancer [30], colon cancer and ovarian cancer [31]. Here, LGR5 is linked to colonic neoplasm.